Chromosome 22q Deletion

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Status:
Unknown status
Last Changed:
Feb 25, 2014
First Changed:
Feb 25, 2014
Disease(s):
22q11 Deletion Syndrome
Intervention(s):
omega-3 PUFAsStandard careplacebo
Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study
Status:
Unknown status
Last Changed:
Sep 7, 2016
First Changed:
Sep 7, 2016
Disease(s):
22q11 Deletion Syndrome Di George Syndrome

Connect. Empower. Inspire.